Business ❯ Pharmaceutical Industry

Manufacturing

Quality Control Quality Assurance Investment Domestic Production Supply Chain Chemical Manufacturing Supply Chain Management Active Pharmaceutical Ingredients Product Safety Safety Regulations Product Distribution Trade Relations Job Creation Factory Operations Domestic Manufacturing Drug Production Licensing Innovation Small and Medium Enterprises Generic Drugs Reshoring Trade Negotiations Special Economic Zones Supply Chain Resilience Baxter International Production Facilities GlaxoSmithKline Export Regulations Aveo Pharmaceuticals Export Practices Counterfeit Products Import/Export Tariffs Drug Manufacturing Safety Standards Chemical Processing Chemical Production Workplace Environment Safety Protocols Regulatory Affairs Illegal Operations Import Regulations Medical Devices US Manufacturing Production Processes U.S. Manufacturing Product Quality Product Recalls Product Development Process Management Quality Standards Product Liability Sresan Pharmaceuticals Compliance Costs Small Enterprises Small Businesses Supply Chain Issues Retail Sector Environmental Compliance Global Supply Chain Cost Management Regulations Biologics Production Drug Supply Chain Production Locations Drug Development Technological Advancements Regulatory Compliance Local Production Product Labeling Bio-Manufacturing Production Capacity Distribution Sanofi Workplace Safety

FDA Works With Manufacturers to Expand Supply of Estradiol Menopause Patches

The agency is offering expedited reviews and operational support to help producers increase output.

FDA Classifies Chlorthalidone Recall as Class II

Nationwide Recall of 25 mg Chlorthalidone Covers 11,460 Bottles

Novartis Breaks Ground on Texas Plant to Speed Radioligand Cancer Drug Delivery

FDA Upgrades Children’s Ibuprofen Recall to Class II Over Reports of Foreign Material

Trump Promotes Drug-Price Push and Reshoring on Cincinnati-Area Swing, Backs Massie Challenger

FDA Eases CMC Rules for Cell and Gene Therapies to Speed Development

FDA Fast-Tracks Augmentin XR in First Approval Under National Priority Voucher Pilot

Teva, Amerisource Pull 580,000+ Prazosin Bottles as FDA Flags Nitrosamine Contamination

Ascend Recalls 141,984 Bottles of Generic Atorvastatin Over Dissolution Failures

TrumpRx–Pfizer Drug-Price Deal Leaves Key Details Unclear

Trump Orders Swift Filling and Expansion of Strategic API Reserve

FDA Launches PreCheck to Accelerate Domestic Drug Plants